34 related articles for article (PubMed ID: 21771750)
1. A New Method for the Measurement of International Normalized Ratio in Hemodialysis Patients with Heparin-Locked Tunneled Dialysis Catheters.
Seghers CB; Ver Elst K; Claessens J; Weekx S; Vermeiren S; Henckes M
Int J Nephrol; 2020; 2020():7586437. PubMed ID: 33425390
[TBL] [Abstract][Full Text] [Related]
2. Atrial fibrillation in dialysis patients: is there a place for non-vitamin K antagonist oral anticoagulants?
Mlodawska E; Lopatowska P; Malyszko J; Banach M; Sobkowicz B; Covic A; Tomaszuk-Kazberuk A
Int Urol Nephrol; 2018 Sep; 50(9):1633-1642. PubMed ID: 29785661
[TBL] [Abstract][Full Text] [Related]
3. Use of oral anticoagulants in patients with atrial fibrillation and renal dysfunction.
Potpara TS; Ferro CJ; Lip GYH
Nat Rev Nephrol; 2018 May; 14(5):337-351. PubMed ID: 29578207
[TBL] [Abstract][Full Text] [Related]
4. Chronic kidney disease and anticoagulation: from vitamin K antagonists and heparins to direct oral anticoagulant agents.
Sciascia S; Radin M; Schreiber K; Fenoglio R; Baldovino S; Roccatello D
Intern Emerg Med; 2017 Dec; 12(8):1101-1108. PubMed ID: 28929298
[TBL] [Abstract][Full Text] [Related]
5. Atrial Fibrillation and Oral Anticoagulation in Chronic Kidney Disease.
Engelbertz C; Reinecke H
J Atr Fibrillation; 2012; 4(6):445. PubMed ID: 28496732
[TBL] [Abstract][Full Text] [Related]
6. Time in Therapeutic Range and Outcomes After Warfarin Initiation in Newly Diagnosed Atrial Fibrillation Patients With Renal Dysfunction.
Szummer K; Gasparini A; Eliasson S; Ärnlöv J; Qureshi AR; Bárány P; Evans M; Friberg L; Carrero JJ
J Am Heart Assoc; 2017 Mar; 6(3):. PubMed ID: 28249846
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Atrial Fibrillation and Antithrombotic Therapy in Hemodialysis Patients: Cross-Sectional Results of the Vienna InVestigation of AtriaL Fibrillation and Thromboembolism in Patients on HemoDIalysis (VIVALDI).
Königsbrügge O; Posch F; Antlanger M; Kovarik J; Klauser-Braun R; Kletzmayr J; Schmaldienst S; Auinger M; Zuntner G; Lorenz M; Grilz E; Stampfel G; Steiner S; Pabinger I; Säemann M; Ay C
PLoS One; 2017; 12(1):e0169400. PubMed ID: 28052124
[TBL] [Abstract][Full Text] [Related]
8. Safety of warfarin therapy in chronic hemodialysis patients: a prospective cohort study.
Hayashi M; Abe T; Iwai M; Matsui A; Yoshida T; Sato Y; Kanno Y;
Clin Exp Nephrol; 2016 Oct; 20(5):787-794. PubMed ID: 26627501
[TBL] [Abstract][Full Text] [Related]
9. Oral anticoagulant therapy in patients receiving haemodialysis: is it time to abandon it?
Saracyn M; Brodowska-Kania D; Niemczyk S
ScientificWorldJournal; 2013 Nov; 2013():170576. PubMed ID: 24379737
[TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and risk of stroke in dialysis patients.
Wetmore JB; Ellerbeck EF; Mahnken JD; Phadnis M; Rigler SK; Mukhopadhyay P; Spertus JA; Zhou X; Hou Q; Shireman TI
Ann Epidemiol; 2013 Mar; 23(3):112-8. PubMed ID: 23332588
[TBL] [Abstract][Full Text] [Related]
11. Atrial fibrillation and morbidity and mortality in a cohort of long-term hemodialysis patients.
Genovesi S; Vincenti A; Rossi E; Pogliani D; Acquistapace I; Stella A; Valsecchi MG
Am J Kidney Dis; 2008 Feb; 51(2):255-62. PubMed ID: 18215703
[TBL] [Abstract][Full Text] [Related]
12. Severe renal impairment and stroke prevention in atrial fibrillation: implications for thromboprophylaxis and bleeding risk.
Marinigh R; Lane DA; Lip GY
J Am Coll Cardiol; 2011 Mar; 57(12):1339-48. PubMed ID: 21414530
[TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis of Anticoagulation Use, Stroke, Thromboembolism, Bleeding, and Mortality in Patients With Atrial Fibrillation on Dialysis.
Wong CX; Odutayo A; Emdin CA; Kinnear NJ; Sun MT
Am J Cardiol; 2016 Jun; 117(12):1934-41. PubMed ID: 27237624
[TBL] [Abstract][Full Text] [Related]
14. Coumarins and survival in incident dialysis patients.
Knoll F; Sturm G; Lamina C; Zitt E; Lins F; Freistätter O; Kronenberg F; Lhotta K; Neyer U
Nephrol Dial Transplant; 2012 Jan; 27(1):332-7. PubMed ID: 21771750
[TBL] [Abstract][Full Text] [Related]
15. Relation of the HAS-BLED bleeding risk score to major bleeding, cardiovascular events, and mortality in anticoagulated patients with atrial fibrillation.
Gallego P; Roldán V; Torregrosa JM; Gálvez J; Valdés M; Vicente V; Marín F; Lip GY
Circ Arrhythm Electrophysiol; 2012 Apr; 5(2):312-8. PubMed ID: 22319005
[TBL] [Abstract][Full Text] [Related]
16. Atrial fibrillation in haemodialysis patients: do the guidelines for anticoagulation apply?
To AC; Yehia M; Collins JF
Nephrology (Carlton); 2007 Oct; 12(5):441-7. PubMed ID: 17803466
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
